SSR Inst. Int. J. Life Sci., 9(1): 3151-3161, January 20223

Effect of Vitamin A and D in Hypertensive Disorder of Pregnancy

Dipendra Prasad Yadav¹, Jifang Shi²*

¹Postgraduate Student, Department of Gynecology and Obstetrics, Dali University-671000, China

²Associate Professor, Department of Obstetrics and Gynecology, Dali University-671000, China

^*Address for Correspondence: Dr. Jifang Shi, Associate Professor, Department of Gynecology and Obstetrics, Dali University, Dali, China

E-mail: fcksjf@outlook.com

 

ABSTRACT Background: Severe preeclampsia is the main cause of maternal mortality. The correlation between vitamin D and hypertensive disorder of pregnancy is a controversial topic at present. Whether vitamin D can be used as an index to predict the risk of preeclampsia and when to supplement vitamin D in clinic has become a relatively popular research content. This study aimed to correlate vitamin A and D with hypertensive disorder of pregnancy and to reduce the risk of hypertension in pregnancy.

Methods: This is a Prospective cohort study on 958 pregnant females. The patients were divided into two groups, namely, treatment group and Pregnancy Induced Hypertension (PIH) group. Liquid chromatography-tandem mass spectrometry and high-performance quid gel electrophoresis were used to find vitamin A and D in the blood of each group (HPLC).

Results: There has not been a big difference in between PIH group and the placebo group (p>0.5). Preeclampsia collection and simple preeclampsia group there has been a statistical change in cesarean unit amount and impulsive transfer (p<0.05). The study further found that There is no rise in the likelihood of mild pregnancy complications, and the thing that is different would not be statistically important (p>0.05). Serum vitamin D level is less than 20 ng/ml, which is a risk factor for preeclampsia.

Conclusion: The lack of vitamin A may be associated with the occurrence of hypertensive disorders during pregnancy and the progression of the disease. The lack of vitamin A may increase the risk of severe preeclampsia risk increased.

Keywords: Chronic hypertension, Gestational Hypertension, Hypertensive disorders, Severe Preeclampsia

 

INTRODUCTION- Between 5 and 10% of pregnant women are complicated by hypertension, which include chronic hypertension (CH), gestational hypertension (GH), preeclampsia (PE), and severe preeclampsia ^[1]. The above diseases are the second most common cause of death among mothers around the entire globe, and they are connected to a greater risk of pregnancy loss, infant death, and illness in both baby and mother (e.g., intrauterine growth restriction) ^[2]. Due to how common these diseases are and what happens to people, who have people, it is essential for public wellbeing to find out what causes high blood pressure illnesses during pregnant women.

Severe preeclampsia is the main cause of maternal mortality, commonly cerebral hemorrhage, multiple organ failure, intravascular hemolysis, HELLP syndrome. For the effect of intrauterine fetus, preterm birth, fetal intrauterine distress, fetal intrauterine death, neonatal Apgar score is poor, and even neonatal ischemic hypoxic encephalopathy, which seriously threatens maternal and infant health. HDP not only caused harm to pregnant women and the fetus, it can also pose a potential risk to cardiovascular disease in the mother and children ^[3]. Therefore, to prevent the occurrence of HDP, explore its risk factors, reduce the incidence, early prevention intervention for the mother and children is of great significance. Vitamin is an important substance that the human body cannot produce on its own and needs to intake from the outside world ^[4]. For pregnant women, Vitamin A, and D are more important.

Vitamin is a collective of aromatic hydrocarbons chemical materials which include retinol, retinal, retinoids, as well as several rich in vitamin A carotenoids, greatest notably betacarotene. Vitamin A is crucial for growth and development, keeping the strong immune system and keeping one’s eyes healthy. In the type of retinal, vitamin A is required by the retina of the eye ^[5]. Retinal manages to combine with protein opsin to make photoreceptors, a light-absorbing compound that is required for both low-light (scotopic) and color perception. Vitamin A also works in so many various ways as retinoic acid, which serves as an essential hormone-like factor for epithelial and other cells.

Some research has found that the lack of vitamin D during pregnancy may be associated with a range of adverse pregnancy outcomes, such as gestational diabetes, hypertensive disorder of pregnancy, and other related diseases ^[6]. The correlation between vitamin D and hypertensive disorder of pregnancy is a controversial topic at present. Whether vitamin D can be used as an index to predict the risk of preeclampsia and when to supplement vitamin D in clinic has become a relatively popular research content ^[7].

If the incidence and development of pregnancy induced HDOP are predicted by certain methods before the onset of gestational hypertensive disease, the high-risk factors leading to hypertensive disorder of pregnancy will be reduced, and also reduce the occurrence of maternal and infant diseases, appropriate to improve the survival rate of perinatal infants ^[8]. This experiment is to explore the correlation of VitA and D with hypertensive disorder of pregnancy by measuring the content of Vitamin A and vitamin D in the serum in pregnancy and to reduce the risk of hypertension in pregnancy ^[9].孕母维生素A、D程度既可影响其自己的安康又能够对胎儿及其远期的安康发生影响，但今朝海内对孕母分歧孕期的维生素A、D程度及孕期口服弥补维生素A、D（剂量、机会）的研讨较少，本课题经由过程对怀胎妇女各个孕期血维生素A、D程度的检测，阐发孕母血维生素A、D程度的影响身分及其与怀胎并发症的干系，切磋有益于进步孕妇血维生素A、D浓度的办法，为采纳有针对性的维生素A、D弥补及取得杰出的临蓐终局供给科学根据，相干研讨海内今朝还没有见报道。

 

MATERIALS  

 AND METHODS

Research Design- From June 2017 to May 2018, samples were collected at the initial aid facilities of Dali University in the provincial capital of Yunnan. 958 pregnant women under 35 years old and between 32 and 38 weeks along were all present in the hospital ^[10]. There have been 501 normal pregnant women in the treatment group, 151 in the contractile apparatus, 126 in the pregnancy complications group, and 180 in the serious pregnancy complications group. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and high-performance liquid chromatography, vitamins A and D have been discovered in each cohort (HPLC) ^[11]. The results had been statistically examined. Serum was collected from peripheral venous blood (2 ml) not anticoagulation, and was stored in dark and cool, whole blood sample were centrifuged ^[12].

 

Preeclampsia- Systolic pressure ≥140 mmHg and/or diastolic pressure ≥90 mmHg with proteinuria ≥0.3 g/24 h after 20 weeks of pregnancy, or random urinary protein (+).

 

Severe preeclampsia- Markedly elevated blood pressure (systolic ≥160 mmHg or diastolic ≥110 mm Hg) at least 6 hours apart and proteinuria continue to rise (≥5 g/24 hours or 3+) ^[13]. with manifestation of end-organ disease like renal dysfunction, edema, liver function damage, or hemorrhage, persistent headache, visual symptoms, decrease platelets continuously, intravascular hemolysis, impaired liver function.

 

VitA and D sample collection- Serum was collected from peripheral venous blood (2 ml) not anticoagulation, and was stored in dark and cool, whole blood sample were centrifuged ^[12]. All pregnant women of Age less than 35 and fasting sample.

 

Diagnostic criteria

Gestational hypertension- First occurrence of blood pressure ≥140/90 mmHg during pregnancy, and return to normal after 12 weeks of delivery (postpartum), negative urinary protein. Preeclampsia: systolic pressure ≥140 mmhg and/or diastolic pressure ≥90 mmHg with proteinuria ≥0.3 g/24 h after 20 weeks of pregnancy, or random urinary protein (+).

 

Severe preeclampsia- Markedly elevated blood pressure (systolic ≥160 mmHg or diastolic ≥110 mmHg) at least 6 hours apart and proteinuria continue to rise (≥5 g/24 hours or 3+) ^[11]. with manifestation of end-organ disease like renal dysfunction, edema, liver function damage, or hemorrhage, persistent headache, visual symptoms, decrease platelets continuously, intravascular hemolysis, impaired liver function ^[11,13].

 

Vitamin Diagnostic Criteria  

VitA group

VitA Normal: 0.3-0.7 mg/L

VitA abnormalities:

Elevated: >0.7 mg/L

Deficiency: 0.3 mg/L

VitD Group

Normal: 20-100 ng/mL,

Insufficient: ≤20 ng/mL,

Elevated: ≥100 ng/mL.

 

Inclusion criteria- All pregnant women of Age less than 35 and fasting sample. The patients, who had the first occurrence of blood pressure ≥140/90 mmHg during pregnancy, and return to normal after 12 weeks of delivery (postpartum), had negative urinary protein.

 

Exclusion criteria- This research collects evidence from around 958 pregnant women, who are below 35. This research paper is to explore VitA and D with hypertensive illness during pregnancy by estimating the context of Vitamin A and vitamin D. Therefore, this serum can reduce the risk factors during pregnancy.

 

Statistical Analysis- SPSS 21.0 technology is employed to perform statistical storage and interpretation. Excel2014 is used to obtain information on all the statistics so that a data set can be made. People are using the independent assessment and the Pearson chi-square test. Through using chi-square exam, the percentage of having to count data (%) demonstrates that p<0.05 is statically important ^[14]. Use logistic regression analysis with more than one factor.

 

Ethical Approval- Through this research, the researcher is to obtain approval from the hospital authority to gather evidence regarding the topic. The researcher obtains consent before starting this research. The researcher communicated with patients individually about the topic.

 

RESULTS

General Information- Total of 958 pregnant women were included in the study, the basic information of the research object was expressed by x̄±s, and the difference between the groups was compared by variance analysis. The results showed no significant difference in the age, birth, body mass index (BMI) and pregnancy weekly average of pregnant women (p>0.05) between the groups (Table 1).

 

Table 1: General conditions of pregnant women

Groups	Number of patients (n)	Age (y)	Parity	BMI (kg/m2)	Blood Collection Pregnancy Week (w)
Control group	501	35.89±2	2.07±0.88	21.55±1.37	34.13±1.02
Gestational hypertension	151	34.76±2	1.90±0.86	21.63±1.38	34.03±1.10
Preeclampsia group	126	32.60±2	1.98±0.78	20.78±1.39	34.20±1.03
Severe pre-eclampsia group	180	34.88±2	2.05±0.92	22.65±1.40	34.39±1.14
F-value		2.49	0.25	0.98	0.69
p*		>0.05	>0.05	>0.05	>0.05

p*=0.05

Correlation analysis of Vit A and hypertensive diseases during pregnancy- Increases in the Vit A levels of patients with hypertension during pregnant. The Vit A concentrations of the comparison group, the hypertension in pregnant collective, the hypertension collective, and the serious hypertension group have been 0.40160.1670, 0.37060.1787, 0.21700.1037, and 0.11300.0105, respectively. VitA concentration decreased continuously in hypertension disorders during pregnant, despite the lack of a significant difference between the amount of the hypertension illness group during pregnant women and that of the control group (t=1.9615, p=0.0502) (p>0.05). The contrast between preeclampsia and severe hypertension groups has been statistically significant (t=13.3665, p=0.000) (p<0.05) (Table 2).

 

Table 2: Vit. A content in serum of hypertensive pregnancy

Groups	N	VitA mg/L
Control group	501	0.40 ± 0.16
Gestational hypertension	151	0.37 ±0.17
preeclampsia group	126	0.21 ±0.10
Severe preeclampsia group	180	0.11 ± 0.01

 

Analysis of the changes of hypertensive disease and VitA content during pregnancy- Serum vit A levels were classified according to literature standards. vit A was normal (0.3<vit A <0.7 mg/L). There was a statistically significant difference in the deficiency rate of VitA in the mild (0.2<vitA< 0.3 mg) and severe (vitA<0.2 mg/L). control group, the hypertensive pregnancy group, the  preeclampsia group and the severe preeclampsia group (χ²=840.717, p= 0.000) p<0.05, and the difference of VitA deficiency rate between the preeclampsia group and the severe preeclampsia group was statistically significant (χ²=4.302, p=0.038); p<0.05; When VitA was severely lacking, the proportion of severe preeclampsia was 60%, the mild preeclampsia group was 56%, the gestational hypertension group was 36.4%, and the control group was the smallest (0.4%) ^[15] and the control group accounted for the largest proportion of 99%, while the pregnancy induced hypertension group was 7%, the mild preeclampsia group was 8%, and the proportion of severe preeclampsia group was the smallest 2.8% (Table 3).

 

Table 3: Deficiencies of VitA associated in pregnancy with hypertension

Groups	N	Normal N(%)	Mild deficiency N(%)	Severe deficiency N(%)
Control group	501	496(99)	3 (0.6)	2 (0.4)
Gestational hypertension	151	10(7)	86 (57)	55(36.4)
pre-eclampsia group	126	10(8)	45 (36)	71(56)
Severe pre-eclampsia group	180	5(2.8)	67 (37.2)	108(60)

 

Analysis of the mode of delivery in case of severe vitamin A deficiency and pregnancy induced hypertension- When Vit A was severely deficient, 55 patients (36.7%) in hypertensive pregnancy group and 71 in mild preeclampsia group (56.4%), 109(60.5%) in severe preeclampsia group, and the analysis of delivery modes and good outcomes of pregnancy-induced hypertension in different degrees under severe VitA deficiency were as follows: experimental study found: (1) comparison of delivery modes: there was no significant difference between pregnancy-induced hypertension group and mild preeclampsia group in cesarean section and spontaneous delivery (χ²=0.026, p=0.872) p>0.05; cesarean section was performed in mild preeclampsia group and severe preeclampsia group (Table 4).

 

Table 4: Analysis of the mode of delivery of severe vitA deficiency and in hypertensive pregnancy

Groups	Natural birth N(%)	Cesarean delivery N(%)
Gestational hypertension	33(60)	22(40)
Preeclampsia	42(59)	29(41)
Severe preeclampsia	38(35)	71(65)

 

There was significant difference in spontaneous delivery (χ²= 9.410, p=0.002) p<0.05. (2) Pregnancy outcomes: comparison of postpartum hemorrhage and neonatal ischemia in PIH group, preeclampsia group and severe preeclampsia group hypoxic ischemic encephalopathy (HIE), 1<Apgar score<7, neonatal rescue, etc. were significantly different. (χ²=16.712, p=0.01) p<0.05; postpartum hemorrhage occurred in preeclampsia group and severe preeclampsia group. There were differences in neonatal hypoxic ischemic encephalopathy (HIE), 1<Apgar score <7, neonatal rescue, etc. Statistical significance (χ²= 11.152, p= 0.01) p<0.5 (Table 5).

 

Table 5: Analysis of outcome of severe vitA deficiency and hypertensive disorder of pregnancy

HIE=Hypoxic Ischemic Encephalopathy

VitA Severe deficiency affects the Pathogenesis of Preeclampsia- When serum vitA<0.2 mg/L in the third trimester of pregnancy is relative to ≥0.2 mg/L, preeclampsia group and severe preeclampsia group. The risk of early-stage group increased by 1 and 2 times respectively, and the difference was statistically significant (OR value was 1.46, 95%CI 1.14-7.42: OR 2. 14, 95% CI=1.44-10.22).

 

Multivariate Logistic Regression Analysis to Control Pregnant Women- The risk of severe preeclampsia increased three times after age, gestational age, BMI, and gestational week (p<0.05) (OR value 3.18, 95% CI 1.34-20.09), but the risk of preeclampsia did not increase (p> 0.05) (OR value 1.45, 95% CI 0.20-21.53) (Table 6).

 

Table 6: Incidence risk assessment before correction of serum vitA <0.2 mg/L compared with ≥0.2 mg/L

Groups	Before Correction B(P) OR 95%CI	After Correction B(P) OR 95%CI
preeclampsia	1.27(0.009) 1.46 (1.14-7.42)	1.82(0.103) 1.45 (0.20-21.53)
Severe preeclampsia	1.49(0.010) 2.14 (1.44-10.22)	1.75(0.021) 3.18 (1.34-20.09)

 

Analysis of VitD and hypertensive diseases during pregnancy- Changes of VitD content in hypertensive diseases group during pregnancy. The content of VitD in the control group, gestational hypertension group, preeclampsia group and severe preeclampsia group was 21.05±7.64, 20.45±7.05, 18.54±6.51 and 15.03±5.79, respectively. The content of VitD in hypertensive diseases during pregnancy showed a continuous decline trend. The comparison between groups found that there was no significant difference in VitD content between the hypertensive disease group and control group in Pregnancy (t=0.858, p=0.39) (p>0.05), while comparison VitD content decreased significantly between the remaining groups, and the difference between preeclampsia group and severe preeclampsia was statistically significant (t=4.95, p=0.000) (p<0.05) (Table 7).

 

Table 7: VitD content in serum of hypertensive disease group during pregnancy

 

Analysis of the changes of hypertension disease and VitD content in pregnancy- Serum VitD level is classified in standard manner, which is divided into normal (30-100 ng/ml), deficiency (20~<30 ng/ML) and lack (≤20 ng/M1). There were significant differences in VitD deficiency rates between control group, the preeclampsia group and the severe preeclampsia group (χ²=15.455, p=0.001) (p<0.05), and the  deficiency rate of VitD in severe preeclampsia group and preeclampsia group was statistically significant (χ²=4.302, p=0.038), (p<0.05); when lacking (≤20 ng/m1), the proportion of severe preeclampsia was 65%, the  pre-eclampsia group was 61.0%, the gestational hypertension group was 58%, and the control group was the smallest 53.4%, the difference was statistically significant (χ²=11.826, p=0.001) p<0.05; the proportion of normal VitD content in each group was the lowest, the proportion of severe preeclampsia group was 2.5%. The preeclampsia group was 8.0%, the gestational hypertension group was 8.6%, and the control group was 12.6% (Table 8).

 

Table 8: Lack of distribution of VitD during pregnancy associated with hypertension disease

Groups	N	Normal N(%)	Insufficient N(%)	Deficient N(%)
Control group	501	63(12.6)	170(34)	268(53.4)
Gestational hypertension	151	13(8.6)	49(32.5)	89(58.9)
preeclampsia group	126	10(8)	39(31.)	77(61)
Severe preeclampsia group	180	5(2.5)	58(32)	117(65)

 

Analysis of vit D Deficiency and Delivery Mode in hypertensive pregnancy- Under VitD Deficiency Conditions, 138 in Pregnancy-induced Hypertension Group, 116 in Preeclampsia Group, 176 in Severe Preeclampsia Group, and in vitD Deficiency and Pregnancy-induced Hypertensive Disease Delivery Patterns and Pregnancy Outcomes ^[16].

The results were as follows: (1) Comparisons of delivery modes:

Hypertension in pregnancy, preeclampsia, and severe preeclampsia. The proportions of cesarean section and spontaneous delivery in the PIH group were significantly different (χ²=19.934, p=0.000) (p<0.05); There was significant difference between the pregnancy-induced hypertension group and the preeclampsia group. (χ²=5.033, p=0.025) (p<0.05); Comparisons between preeclampsia group and severe preeclampsia group: The difference was statistically significant (χ²=6.840, p=0.009) (p<0.05). Comparison of pregnancy outcomes: (1) Postpartum hemorrhage and neonatal ischemia in PIH group, preeclampsia group and severe preeclampsia group ^[17]. There were significant differences in hypoxic encephalopathy (HIE), 1≤APGAR score ≤7 and neonatal rescue (χ²=25.208 p=0.000) (p<0.05); (2) There were significant differences between preeclampsia and severe preeclampsia groups (χ²= 9.241, p=0.026) (p<0.05) (Table 9 & 10).

 

Table 9: Analysis of vitD deficiency and delivery mode in hypertensive pregnancy

Groups	Spontaneous labor N(%)	Cesarean delivery N(%)
Gestational hypertension	96(69.5)	42(30.5%)
preeclampsia	64(55.2)	52(44.8)
Severe preeclampsia	70(40.0)	106(60.0)

 

Table 10: Analysis of vitD deficiency and pregnancy outcome

 

The effect of vitD deficiency in the preeclampsia- Preeclampsia occurs when the serum level of 25 (OH) D<20 ng/ml) in the third trimester of pregnancy is higher than or equal to >20 ng/ml. The risk of preeclampsia and severe preeclampsia increased by 3 and 4 times, respectively, with significant differences (OR value). 3.25, 95% CI 1.36-9.45; OR 4.28, 95% CI 1.38 -13.20; multivariate logistic regression. The risk of the preeclampsia group and the severe preeclampsia group increased 4 times and 5 times respectively after controlling factors such as maternal age, parity, BMI, and gestational week of blood collection in late pregnancy, with statistical significance (OR value 4.84. 95% CI 1.91-22.53 OR value 5.19, 95% CI 1.14-23.19) (Table 11).

 

Table 11: Risk assessment 25(OH) D level before <20 ng/ml and >-20 ng/ml

 

DISCUSSION

Relationship between Vit A and hypertensive disorder of pregnancy- Throughout human physiology, most of Tran’s retinol is influenced by vitamin A, and vitamin A affects people like bone density, human growth, and the structure of human embryonic stem cells ^[18]. So much consideration has been given to the link between Vit A and the event and growth of high blood pressure in pregnant women, and several studies have demonstrated that the two are linked. Kolusaril's study of 250 pregnant women with high cholesterol discovered that the influence group's serum vitamin A and its prelude beta-carotene levels were way greater than those of the disease area during the blocking period of pregnancy ^[19]. In this test, it must have been found that the amount of VitA in women with high blood pressure diseases during pregnant women kept going down. When the two groups were especially in comparison, there has been no statistical significance difference between the amount of VitA in the PIH group and that in the control group (p>0.05), but the amount of VitA in the other groups must go down steadily ^[20]. There must have been a significant statistical difference between the pregnancy complications group and the serious pregnancy complications group, and the findings suggest that VitA information may be linked to the event occurring of hypertensive diseases during pregnancy. This study wants to at how high blood pressure and VitA levels alter during pregnancy in women. It was discovered that the prevalence of VitA insufficiency has been different in the influence, PIH, pregnancy complications, and severe hypertension groups (p<0.05). Patients, who have high blood pressure have been less likely to have enough vitamin A in different ways. When serum VitA has been less than 0.2 mg/l (severe insufficiency), more women in the severe high blood pressure group than in the preeclampsia collective and more women in the gestational hypertension community compared to the preeclampsia group. This makes perfect sense since the consequences of high blood pressure during pregnancy in women may be linked to the lack of VitA ^[21]. Serious physical high blood pressure may be more likely to happen when a woman is very hungry. The outcomes of this study display that the amount of A may be associated with the onset and gradual improvement of high blood pressure during pregnant women, which also is one of the most important causes of high blood pressure illness during pregnant women ^[22].

Therefore, at moment, the WHO suggests that women, who live in places in which vitamin A deficiency is common to take vitamin A supplements every day while they are pregnant or breastfeeding ^[23]. Vitamin A palmitate and vitamin A acetate are the most popular methods used as vitamins and supplements. Essential micronutrients and retinoids can also be used as vitamins and supplements ^[24]. In the 21^st century, vitamin A might be more helpful in managing a healthy pregnancy and reducing difficulties in women with HDOP, such as anaemia, post-pregnancy bleeding, cesarean section, and so on., and thus in babies, such as fetal and infant distress, economic expansion restriction, weeks of gestation weight, etc. The number of both has been high and important ^[25-28].

 

An evaluation of serum vitamin D and high blood pressure in pregnant women- People frequently do not receive enough vitamin D, especially in the north. The link between hypertensive disease in pregnant women and vitamin D levels. A large number of pregnant women in Saskatoon, Saskatchewan, do not receive sufficient vitamin D. Women, who already have low levels of vitamin D in their blood are more likely to suffer from high pressure ^[29]. For maximum calcium absorption, individuals need enough 25-hydroxyvitamin D or 25(OH)D. Sometimes when individuals do not have enough, the amount of parathyroid hormone in their body goes up ^[30]. Vitamin D deficiency can be defined in numerous ways, but they all centre on the amount of 25(OH) D in the blood ^[31]. Based on the 25(OH) D level below which the level of parathyroid hormone keeps going up, one correct definition has said that a deficit is less than 50 nmol/L and a deficit is between 52 and 72 nmol/L ^[32].

VitD is a fat-soluble steroid hormone that is mostly made from 7-dehydrocholesterol (C27H44O), when exposed to sunlight ^[33]. 7-dehydrocholesterol (C27H44O) would then be modified into 1,25(OH) 2 D3 in the liver. VitD has many various impacts, such as controlling how calcium and phosphorus are used in the body to keep bones going to grow. In recent times, there has been a lot of concern about the importance of VitD in heart health ^[34]. Research findings have demonstrated that VitD receptor (VDR) in the heart and systemic high blood pressure in the peripheral arteries are mainly dispersed, indicating that the number of heart diseases, like high blood pressure, arteriosclerosis, etc is highly correlated to this ^[35].

Most often natural foods have a lot of vitamin D, and only a small amount can be chosen to take in through food ^[36]. According to the most recent research study of vitamin D levels across the United States, 78.5% of the population and 81.5% of pregnant women do not get enough vitamin D. increasing numbers of studies show that the vitamin D level in maternal serum is too low ^[37], so it is connected to the health of both the mother and the baby.

The most time has been given to the connection between VitD and high blood pressure illnesses that happen or get worse during pregnancy women ^[38]. It must have been discovered that as high blood pressure in pregnant women can get worse, serum 25(OH)D levels would go, and the risk of pregnancy complications went up significantly when serum Vitamin D levels have been less than 10 ng/ml. The outcomes show that the number of vitamin D in women with high blood pressure illnesses kept going down during pregnancy ^[39]. There has been no substantial difference between several PIH groups and the control group during pregnancy (p>0.05), however, the amount of vitamin D in the other communities must go down massively. The thing that is different between the high blood pressure group and the serious preeclampsia group was significant statistically (p<0.05) ^[40]. High blood pressure disease in pregnant women may be more likely to develop when there is a lot of vitamin D in the body ^[41]. Throughout this trial, humans have spoken about how hypertension and VitD levels alter during pregnancy in women ^[42]. People also found that there may be a statistically significant distinction between the Vitamin -D deficiency percentage in the comparison group, the pregnancy complications group, and the serious pregnancy complications group ^[43]. Deficiency of vitamin D is more common in women with preeclampsia compared to those with pregnancy complications or gestational. The level of vitamin D is linked to cardiovascular disease disorders in pregnant women, and it is among the most essential causes of high blood pressure in pregnant women ^[44].

Only a small number of studies have looked at how VDBP levels alter over time during pregnancy in women ^[45]. The length of the rise changed over time, with the greatest concentration being 40–50% higher than in nonpregnant women. The rise was at its greatest at the beginning of the second trimester and decided to start to go down after the baby was born. Throughout most research, when the level of VDBP increases, the level of calcitriol also went up ^[46]. As expected, there was a negative relationship between free 25(OH) D and VDBP initial concentration, which meant that free 25(OH) D kept going down from 15 to 36 weeks ^[47].

During pregnant women, there are big changes in vitamin D cell function that lead to a distinctive dynamic process. This is done so that the developing embryo and infectious system can function as well as possible during the pregnancy ^[48]. In particular, there are big improvements in the levels of calcitriol and VDBP in the mother during pregnancy, however, there are no modifications in the levels of 25(OH)D or calcium. This is true even though the baby's vitamin D stores depend on the mothers. A critical component in this sovereign state of vitamin D balance is the requirement for the mother's immune response to be open and accepting of the fetus ^[49]. This would be highly influenced by the placenta, which has been thought to be the main source of immune activation at the interface between the mother and the fetus. Though, every bad pregnant woman’s result that is linked to low levels of vitamin D must be looked at from the point of view of systemic inflammation at both the structural and placental levels ^[50]. More research is required to fully understand how taking supplements of vitamin D during pregnancy women could help with autoimmune conditions ^[51]. Preeclampsia and severe preeclampsia have always been related with a considerable drop in VitA concentration ^[51].

 

CONCLUSIONS- The contents of vit A and D are related to the occurrence of hypertensive disorder during pregnancy. The lack of vitamin A correlates with the occurrence and progression of hypertensions disorder but severe deficiency of vitA increases the risk of severe preeclampsia. The vitA level of blood serum in the third trimester of pregnancy <0.2 mg/L, increased the risk for both preeclampsia and severe preeclampsia. The degree of vit D deficiency was positively correlated with the hyp tensive disorder of pregnancy.

The serum vit D level of 20 ng/ml was a risk factor for preeclampsia. Serum levels of vitA and D during pregnancy can help in predicting pregnancy-induced hypertension.

 

CONTRIBUTION OF AUTHORS

Research concept- Jifang Shi

Research design- Jifang Shi

Supervision- Jifang Shi

Materials- Dipendra Prasad Yadav

Data collection- Dipendra Prasad Yadav

Data analysis and Interpretation- Dipendra Prasad Yadav

Literature search- Dipendra Prasad Yadav

Writing article- Dipendra Prasad Yadav

Critical review- Jifang Shi

Article editing- Jifang Shi

Final approval- Jifang Shi

 

REFERENCES

1.     Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol., 2000; 183: 1-22. Available at: https://doi.org/10.1067/mob.2000.107928.

2.     Roberts JM, Pearson G, Cutler J, Lindheimer M, Pregnancy NWGoRoHD. Summary of the NHLBI Working Group on Research on Hypertension during Pregnancy. Hypertens., 2003; 41: 437-45.

3.     Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy, 2003; 22: 203-12.

4.     Ananth CV, Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality. Epidemiol., 2010; 21: 118-123 

5.     Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy, 2001; 20.

6.     Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol., 2014; 144: 138-45.

7.     Cardús A, Parisi E, Gallego C, Aldea M, Fernández E, et al. Valdivielso JM. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int., 2006; 69: 1377-84.

8.     Li YC, Kong J, Wei M, Chen ZF, Liu SQ, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest., 2002; 110: 229-38.

9.     Harvey NC, Holroyd C, Ntani G, Javaid K, Cooper P, et al. Vitamin D supplementation in pregnancy: A systematic review. Health Technol Assess., 2014; 18(45): 1-190.

10.  Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ, 2013; 346: 1169.

11.  Purswani JM, Gala P, Dwarkanath P, Larkin HM, Kurpad A, et al. The role of vitamin D in pre-eclampsia: a systematic review. BMC Pregnancy Childbirth., 2017; 17: 231.

12.  Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, et al. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomized trials. BMJ, 2017; 359: 5237.

13.  Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers’ cohort. Int J Epidemiol., 2013; 42: 97-110.

14.  Boyd A, Golding J, Macleod J, et al. Cohort Profile: the ‘children of the 90s’the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol., 2013; 42: 111-27.

15.  Bendik I, Friedel A, Roos FF, Weber P, Eggersdorfer M. Vitamin D: a critical and essential micronutrient for human health. Front. Physiol., 2014; 5(6): 231-48.

16.  Shakur YA, Tarasuk V, Corey P, O'Connor DL. A comparison of micronutrient inadequacy and risk of high micronutrient intakes among vitamin and mineral supplement users and nonusers in Canada. J Nutr., 2012; 142(3): 534-40.

17.  Novaković R, Cavelaars A, Geelen A, Nikolić M, Altaba II, et al. Review Article Socio-economic determinants of micronutrient intake and status in Europe: A systematic review. Public Health Nutr., 2014; 17(5): 1031-45.

18.  Tanumihardjo SA. Vitamin A: biomarkers of nutrition for development. Am J Clin Nutr., 2011; 94: 658-65.

19.  Wolf G. The discovery of the visual function of vitamin A. J Nutr., 2001; 131: 1647-50.

20.  Reddy GB, Pullakhandam R, Ghosh S, Boiroju NK, Tattari S, et al. Vitamin A deficiency among children younger than 5 y in India: an analysis of national data sets to reflect on the need for vitamin A supplementation. Am J Clin Nutr., 2021; 113: 939-47.

21.  Arlappa N. Sample size covered for serum vitamin A is not nationally representative: data are not suggestive for Targeted Vitamin A Supplementation Programme in India. Am J Clin Nutr., 2021; 113(6): 1708-09.

22.  Berdanier C. Advanced Nutrition Micronutrients. CRC Press, 1997; 22-39.

23.  Arlappa N. Vitamin A supplementation policy: A shift from universal to geographical targeted approach in India considered detrimental to health and nutritional status of under 5 years children. Eur J Clin Nutr., 2022; 28: 1–6.

24.  DeMan J. Principles of food chemistry (3^rd ed.). Maryland: Aspen publication Inc., 1999; pp. 358.

25.  Global prevalence of vitamin A deficiency in populations at risk 1995-2005. WHO global database on vitamin A deficiency. WHO, 2009.

26.  Black RE, Allen LH, Bhutta ZA, Caulfield LE, De onis M, et al. Maternal and child under nutrition. Global and regional exposure and health consequences. Lancet, 2008; 371: 243-60.

27.  Sekabira H, Nansubuga Z, Ddungu SP, Nazziwa L. Farm production diversity, household dietary diversity, and nutrition: Evidence from Uganda's national panel survey. PLoS One, 2022; 17(12): 121-41.

28.  Wirth JP, et al. Vitamin A Supplementation Programs and Country-Level Evidence of Vitamin A Deficiency. Nutr., 2017; 9(3): 190.

29.  Akhtar S, Ahmed A, Randhawa MA, Atukorala S, Arlappa N, et al. Prevalence of vitamin A deficiency in south Asia: causes, outcomes, and possible remedies J Health Pop Nutr., 2013; 31: 413-23.

30.  Combs GF. The vitamins: Fundamental Aspects in Nutrition and Health (3^rd ed.). Burlington: Elsevier Academic press, 2008.

31.  Zeba AN, Sorgho H, Rouamba N, Zongo I, Rouamba J, et al. Major reduction of malaria morbidity with combined vitamin A and zink supplementation in young children in Burkina faso: a randomized double blindtrial. Nutr J., 2008; 7:7.

32.  Roncone DP. Xerophthalmia secondaryto alcohol induced malnutrition. Optometry, 2006., 77; 124-33.

33.  Strobel M, Tinz J, Biesalski HK. The importance of beta carotene as a source of vitamin A with special regard to pregnant and breastfeeding women. Eur J Nutr., 2007; 1: 11-20.

34.  Schulz C, Engel U, Kreienberg R, Biesalski HK. Vitamin A and beta-cartene supply of women with gemini or short birth interval: a pilot study. Eur J Nutr., 2007; 46: 12-20.

35.  Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell, 2008; 134: 921-31.

36.  Kolusari A, Kurdoglu M, Yildizhan, R Adali E, Edirne T, et al. Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D and E levels in pre-eclampsia. Jint Med Res., 2008; 36: 1335-41.

37.  Radhika MS, Bhaskaram P, Balakrishna N, Ramalakshmi BA. Red palm oil supplementation: a feasible diet-based approach to improve the vitamin A status of pregnant women and their infants. Food Nutr Bull., 2003; 24: 208-17.

38.  Genuis SJ, Schwalfenberg GK, Hiltz MN et al. Vitamin D status of clinical practice populations at higher latitudes: analysis and applications. Int J Environ Res Public Health, 2009; 6: 151-73.

39.  Huotari A, Herzig KH. Vitamin D and living in northern latitudes--an endemic risk area for vitamin D deficiency. Int J Circumpolar Health, 2008; 67: 164-78.

40.  Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab., 1988; 67: 373-78.

41.  Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol., 2009; 19: 73-78.

42.  Holick MF. Vitamin D deficiency. N Engl J Med., 2007; 357: 266-81.

43.  Bhattacharyya MH, DeLuca HF. The regulation of the rat liver calciferol-25-hydroxylase. J Biol Chem., 1973; 248: 2969-73.

44.  Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW. Cloning, structure, and expression of the mitochondrial cytochrome P450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem., 1989; 264: 8222-29.

45.  Halloran BP, DeLuca HF. Calcium transport in small intestine during pregnancy and lactation. Am J Physiol Endocrinol Metab., 1980; 239: 64-68.

46.  Pahuja D, Deluca H. Stimulation of intestinal calcium transport and bone calcium mobilization by prolactin in vitamin D-deficient rats. Sci., 1981; 214: 1038-39.

47.  Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3: significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest., 1981; 67: 589-96.

48.  Zhang J, Lucey A, Horgan R, Kenny L, Kiely M. Impact of pregnancy on vitamin D status: a longitudinal study. Br J Nutr., 2014;112: 1081-87.

49.  Wagner CL, Hollis BW, Kotsa K, Fakhoury H, Karras SN. Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Rev Endocr Metab Disord., 2017; 18: 307-22.

50.  Vijayaraghavan K. National control programme against nutritional blindness due to vitamin A deficiency: Current status & future strategy. Indian J Med Res., 2018; 148(5): 496-502.

51.  Duan S, Jiang Y, Mou K, Wang Y, Zhou S, et al. Correlation of serum vitamin A and vitamin E levels with the occurrence and severity of preeclampsia. Am J Transl Res., 2021; 13(12): 14203-10.